760 related articles for article (PubMed ID: 16342849)
21. Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
Nahrstedt A; Butterweck V
J Nat Prod; 2010 May; 73(5):1015-21. PubMed ID: 20408551
[TBL] [Abstract][Full Text] [Related]
22. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
Sarris J; Kavanagh DJ
J Altern Complement Med; 2009 Aug; 15(8):827-36. PubMed ID: 19614563
[TBL] [Abstract][Full Text] [Related]
23. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem).
Murch SJ; Rupasinghe HP; Saxena PK
Planta Med; 2002 Dec; 68(12):1108-12. PubMed ID: 12494339
[TBL] [Abstract][Full Text] [Related]
24. Comparison of German St. John's wort products according to hyperforin and total hypericin content.
Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilavecz M
J Am Pharm Assoc (Wash); 2001; 41(4):560-6. PubMed ID: 11486982
[TBL] [Abstract][Full Text] [Related]
25. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
[TBL] [Abstract][Full Text] [Related]
26. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
Röder C; Schaefer M; Leucht S
Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
[TBL] [Abstract][Full Text] [Related]
27. St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
Kholghi G; Arjmandi-Rad S; Zarrindast MR; Vaseghi S
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):629-642. PubMed ID: 35294606
[TBL] [Abstract][Full Text] [Related]
28. Effect of St. John's wort on free radical production.
Hunt EJ; Lester CE; Lester EA; Tackett RL
Life Sci; 2001 Jun; 69(2):181-90. PubMed ID: 11441908
[TBL] [Abstract][Full Text] [Related]
29. Hyperforin in extracts of St John's wort (Hypericum perforatum) for depression.
Vormfelde SV; Poser W
Arch Intern Med; 2000 Sep; 160(16):2548-9. PubMed ID: 10979074
[No Abstract] [Full Text] [Related]
30. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
32. Role of hyperforin in the pharmacological activities of St. John's Wort.
Zanoli P
CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771
[TBL] [Abstract][Full Text] [Related]
33. Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: a possible role of hyperforin.
Tadros MG; Mohamed MR; Youssef AM; Sabry GM; Sabry NA; Khalifa AE
Behav Brain Res; 2009 May; 199(2):334-9. PubMed ID: 19136030
[TBL] [Abstract][Full Text] [Related]
34. St John's wort for depression: a systematic review.
Gaster B; Holroyd J
Arch Intern Med; 2000 Jan; 160(2):152-6. PubMed ID: 10647752
[TBL] [Abstract][Full Text] [Related]
35. Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials.
Trautmann-Sponsel RD; Dienel A
J Affect Disord; 2004 Oct; 82(2):303-7. PubMed ID: 15488262
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA
Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964
[TBL] [Abstract][Full Text] [Related]
37. Determination of total hypericins in St. John's wort and herbal medicinal products.
Anyzewska M; Kowalczuk A; Łozak A; Jabłczyńska R; Fijałek Z
Acta Pol Pharm; 2010; 67(6):586-92. PubMed ID: 21229872
[TBL] [Abstract][Full Text] [Related]
38. Researching the antidepressant actions of Hypericum perforatum (St. John's wort) in animals and man.
Franklin M; Cowen PJ
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S29-37. PubMed ID: 11518072
[TBL] [Abstract][Full Text] [Related]
39. St John's Wort and literature quotations.
Mennini T; Gobbi M; Morazzoni P
Arch Intern Med; 2001 Apr; 161(7):1016-7. PubMed ID: 11295979
[No Abstract] [Full Text] [Related]
40. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Phillipson JD
J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
